Clinical trials
Phase 1/2 Immune System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 7 |
| Terminated | 7 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alladapt Immunotherapeutics, Inc. | 2 |
| Celgene | 2 |
| Inmagene LLC | 2 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Cabaletta Bio | 1 |
| Celularity Incorporated | 1 |
| Curis, Inc. | 1 |
| Eledon Pharmaceuticals | 1 |
| Intellia Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 25 |
| Immunoproliferative Disorders | 9 |
| Lymphoma | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Lymphoproliferative Disorders | 8 |
| Lymphatic Diseases | 7 |
| Neoplasms | 6 |
| Autoimmune Diseases | 5 |
| Lymphoma, B-Cell | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.